Bioactive Hydrogel Heparin PEG Crosslinking
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing bioactive hydrogels lack versatility in physical and biochemical properties, are restricted in mechanical properties, and fail to adequately support complex regenerative processes, including cell adhesion, signal molecule binding, and modular functionality.
Innovation Solution
A bioactive hydrogel composed of heparin and star-branched polyethylene glycol with functionalized end groups, where heparin is bound covalently via amide bonds or enzyme-cleavable peptide sequences, allowing for controlled gel formation and modification to achieve varied physical and biochemical properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If hydrogels with synthetic or biological main components are used to provide structural support and protection for regenerating cells, then the carrying and supporting function is improved, but the control over cell adhesion and the binding/release of signal molecules is insufficient
Solution Approach 1:
The hydrogel is segmented into distinct functional domains: star-branched PEG provides structural support through its branched architecture, while heparin segments provide signal molecule binding capability. This segmentation allows each component to independently fulfill its specific function without compromising the other.
Solution Approach 2:
The invention combines synthetic star-branched PEG and biological heparin into a composite hydrogel material. This composite structure integrates the mechanical stability of synthetic polymers with the bioactivity of natural ECM components, achieving both structural support and controlled signal molecule binding/release functions.
2Stability of the object's composition
If crosslinking chemistry is used to provide mechanical stability to hydrogels, then the structural integrity is improved, but the range of mechanical properties such as stiffness and swelling is restricted
Solution Approach 1:
The invention enables parameter changes by varying the heparin-to-PEG ratio, crosslinking density, and molecular weight of components. These parameter adjustments allow continuous tuning of mechanical properties including stiffness, swelling ratio, and degradation rate, while maintaining structural integrity through the stable amide bond crosslinking.
3Reliability
If natural ECM components are used to provide bioactivity and cell interaction, then the biocompatibility is improved, but the mechanical properties and structural stability are limited
Solution Approach 1:
The hydrogel combines natural heparin for biocompatibility and signal molecule binding with synthetic star-branched PEG for mechanical stability. This composite approach allows the natural component to provide bioactivity while the synthetic component compensates for mechanical limitations.
Solution Approach 2:
The star-branched PEG backbone serves multiple functions: providing structural framework, enabling crosslinking for mechanical stability, and offering adjustable architecture through its branched structure. This multi-functionality allows a single synthetic component to support multiple requirements of the hydrogel system.
4Reliability
If highly hydrated materials are used to support regenerative processes, then the biocompatibility and cell-friendly environment are improved, but the mechanical strength and structural stability decrease
Solution Approach 1:
The hydrogel exhibits local quality differentiation where the highly hydrated regions provide biocompatibility and nutrient diffusion, while the star-branched PEG crosslinked network provides localized mechanical strength. This spatial differentiation of properties allows simultaneous achievement of soft, cell-friendly environments and structural integrity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The hydrogel provides a biocompatible, degradable scaffold with adjustable stiffness and swelling, enabling controlled cell adhesion, reversible signal molecule binding, and modular restructuring, suitable for regenerative therapies and tissue replacement.
Implementation Method 1
the heparin is bound directly by 1-ethyl-3-(3-dimethylaminopropyl) carbodiimides/N-hydroxysulfosuccinimide (EDC/s-NHS) activated carboxyl groups of heparin to the terminal amino groups of the polyethylene glycol covalently by amide bonds
Implementation Method 2
combinations of synthetic and polysaccharide-based components of the natural ECM have also been developed, which exploit the special affinity of these molecules for important signal molecules, for example growth factors
Data Source
AI summary
The invention relates to a bioactive hydrogel as a hybrid material of heparin and star-branched polyethylene glycol with functionalized end groups, wherein the heparin is bound directly by reaction of the carboxyl groups activated with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimides/N-hydroxysulfosuccinimide (EDC/s-NHS) with the terminal amino groups of the polyethylene glycol covalently by amide bonds.
